X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1294) 1294
Publication (83) 83
Book Review (19) 19
Newsletter (13) 13
Book Chapter (7) 7
Magazine Article (5) 5
Book / eBook (3) 3
Conference Proceeding (2) 2
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1030) 1030
lactulose (683) 683
lactulose - therapeutic use (592) 592
male (581) 581
female (544) 544
index medicus (448) 448
middle aged (377) 377
gastroenterology & hepatology (347) 347
adult (342) 342
aged (249) 249
hepatic encephalopathy - drug therapy (248) 248
treatment outcome (206) 206
gastrointestinal agents - therapeutic use (202) 202
hepatic encephalopathy (194) 194
double-blind (179) 179
constipation - drug therapy (159) 159
constipation (155) 155
animals (146) 146
permeability (128) 128
hepatic encephalopathy - etiology (126) 126
hepatic encephalopathy - therapy (124) 124
adolescent (122) 122
child (122) 122
liver cirrhosis - complications (122) 122
pharmacology & pharmacy (120) 120
cirrhosis (116) 116
disaccharides - therapeutic use (113) 113
care and treatment (111) 111
rifamycins - therapeutic use (107) 107
rifaximin (103) 103
chronic disease (101) 101
medicine, general & internal (98) 98
diagnosis (97) 97
hepatic encephalopathy - diagnosis (97) 97
anti-bacterial agents - therapeutic use (96) 96
liver cirrhosis (91) 91
double-blind method (90) 90
probiotics (87) 87
ammonia - blood (86) 86
cathartics - therapeutic use (86) 86
ammonia (84) 84
research (84) 84
child, preschool (83) 83
pediatrics (83) 83
lactulose - metabolism (82) 82
lactulose - administration & dosage (81) 81
polyethylene glycols - therapeutic use (80) 80
gastroenterology (79) 79
medicine & public health (79) 79
management (78) 78
portal-systemic encephalopathy (76) 76
efficacy (75) 75
probiotics - therapeutic use (75) 75
prospective studies (75) 75
rats (75) 75
analysis (74) 74
children (74) 74
breath tests (72) 72
intestinal permeability (72) 72
time factors (72) 72
intestine (70) 70
irritable bowel syndrome (69) 69
health aspects (68) 68
lactulose - adverse effects (68) 68
lactulose - pharmacology (68) 68
neomycin - therapeutic use (67) 67
oncology (65) 65
nutrition & dietetics (64) 64
prevalence (64) 64
abridged index medicus (63) 63
risk factors (63) 63
irritable-bowel-syndrome (62) 62
laxatives (61) 61
severity of illness index (59) 59
hepatology (58) 58
mannitol (57) 57
lactulose - urine (56) 56
cirrhotic-patients (55) 55
constipation - therapy (55) 55
aged, 80 and over (53) 53
laxatives - therapeutic use (53) 53
quality of life (53) 53
biochemistry, general (52) 52
liver cirrhosis - drug therapy (52) 52
young adult (52) 52
clinical trials (51) 51
clinical trials as topic (50) 50
diarrhea (50) 50
infant (50) 50
randomized controlled trials as topic (49) 49
ammonia - metabolism (48) 48
gastroenterology and hepatology (48) 48
hepatic encephalopathy - physiopathology (48) 48
microbiota (48) 48
drug therapy, combination (47) 47
administration, oral (46) 46
polyethylene glycol (46) 46
metabolism (45) 45
diet (44) 44
intestinal mucosa - metabolism (44) 44
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1152) 1152
German (55) 55
Italian (21) 21
French (19) 19
Russian (18) 18
Chinese (14) 14
Japanese (10) 10
Spanish (10) 10
Dutch (6) 6
Danish (3) 3
Hungarian (3) 3
Polish (3) 3
Ukrainian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Czech (1) 1
Korean (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Cochrane database of systematic reviews, ISSN 1469-493X, 2015, Volume 5, Issue 5, p. CD003448
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2016, Volume 2016, Issue 8, p. CD009118
Background Constipation within childhood is an extremely common problem. Despite the widespread use of osmotic and stimulant laxatives by health professionals... 
CONTROLLED-TRIAL | MAGNESIUM-HYDROXIDE | Dietary Fiber [adverse effects; therapeutic use] | Humans | Child, Preschool | Infant | PSYLLIUM FIBER | Osmosis | Mineral Oil [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | Polyethylene Glycols [adverse effects; therapeutic use] | POLYETHYLENE-GLYCOL 3350 | Child | Lactulose [adverse effects; therapeutic use] | HYDROLYZED GUAR GUM | PLUS ELECTROLYTES | Laxatives [adverse effects; therapeutic use] | LIQUID PARAFFIN | Constipation [drug therapy] | Magnesium Hydroxide [adverse effects; therapeutic use] | Randomized Controlled Trials as Topic | Defecation [drug effects; physiology] | CHRONIC FUNCTIONAL CONSTIPATION | Sugar Alcohols [adverse effects; therapeutic use] | Adolescent | DOUBLE-BLIND | RECTAL FECAL IMPACTION | Lactulose - adverse effects | Defecation - drug effects | Polyethylene Glycols - adverse effects | Laxatives - therapeutic use | Magnesium Hydroxide - adverse effects | Polyethylene Glycols - therapeutic use | Sugar Alcohols - therapeutic use | Laxatives - adverse effects | Sugar Alcohols - adverse effects | Magnesium Hydroxide - therapeutic use | Dietary Fiber - therapeutic use | Mineral Oil - adverse effects | Dietary Fiber - adverse effects | Mineral Oil - therapeutic use | Defecation - physiology | Constipation - drug therapy | Lactulose - therapeutic use
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2010, Volume 362, Issue 12, pp. 1071 - 1081
Journal Article